$100M Walgreens Class Action Settlement 2025: In 2025, Walgreens agreed to a $100 million settlement in a class action lawsuit alleging the company overcharged insured customers for generic prescription drugs. The lawsuit accused Walgreens of improperly inflating its “usual and customary” prices for medications, which affected the insurance reimbursements for many customers. This settlement aims to compensate those affected by these practices from January 1, 2007, to November 18, 2024.
$100M Walgreens Class Action Settlement 2025
The $100 million Walgreens class action settlement offers an opportunity for eligible individuals and entities who were overcharged for prescription drugs at Walgreens. By understanding the eligibility criteria, deadlines, and how to file a claim, affected parties can ensure they receive the compensation they deserve. It’s important to act quickly, as deadlines for filing claims or opting out are fast approaching.
| Key Aspect | Details |
|---|---|
| Settlement Amount | $100 million |
| Class Period | January 1, 2007 – November 18, 2024 |
| Eligibility Criteria | Individuals/entities who paid for prescriptions at Walgreens using insurance during the class period |
| Claim Deadline | April 17, 2025 |
| Official Settlement Website | SavingsClubSettlement.com |
Background of the Settlement
The lawsuit, Russo et al. v. Walgreen Co., accused Walgreens of using prices from its Prescription Savings Club (PSC) membership program to set its “usual and customary” prices. The issue arose because insured customers, who were entitled to lower rates under their health plans, ended up paying higher prices, while PSC members got discounted rates. By failing to incorporate the lower PSC prices in its billing practices for insurance reimbursements, Walgreens allegedly overcharged insurers and, by extension, consumers.
Walgreens denied any wrongdoing, asserting that the claims lacked merit. However, they decided to settle the case to avoid protracted litigation and the associated costs. The settlement will compensate those affected by this pricing issue over nearly two decades. This is a significant development, as many consumers were unaware of the price discrepancies, and the settlement brings awareness to the issue of how drug prices are set and the importance of transparency in pharmaceutical pricing.
Who Is Eligible for the Settlement?
To participate in the settlement, individuals and entities must meet the following criteria:
- Individuals: Those who paid, in whole or in part, for prescription drugs at Walgreens using insurance benefits between January 1, 2007, and November 18, 2024. This applies to those who had insurance coverage, including private health insurance, government programs like Medicare and Medicaid, or employer-provided health benefits.
- Third-Party Payors: This includes insurers, government programs, or other entities that paid for prescriptions on behalf of their insured or members between January 1, 2007, and November 18, 2024. Third-party payors who covered prescription drug costs during this time period are also eligible to file claims.
It is important to note that those who did not use insurance to pay for prescriptions or those who worked for Walgreens or its affiliates are excluded from the settlement.
Settlement Benefits and Distribution
The total amount of the settlement fund is $100 million. The net fund will be divided into two main categories:
- Individual Claimants: 20% of the net settlement fund will be distributed to individuals who were affected by the pricing discrepancies. The distribution will be done on a pro rata basis, meaning that the amount each claimant receives will be proportional to the amount they paid for eligible prescriptions during the class period.
- Third-Party Payors: 80% of the net settlement fund will be allocated to third-party payors, such as insurers or government programs. This amount will also be distributed on a pro rata basis based on how much was paid for eligible prescriptions.
Each eligible claimant will receive a portion of the fund, though the exact amount will depend on their share of the total prescription payments during the class period.
Important Dates to Remember
To ensure you don’t miss out on this opportunity, here are some key dates to keep in mind:
- Claim Submission Deadline: April 17, 2025 – All claims must be submitted by this date, whether online or via mail.
- Exclusion (Opt-Out) and Objection Deadline: March 18, 2025 – If you wish to opt out of the settlement or object to its terms, you must do so by this date.
- Final Approval Hearing: September 10, 2025 – This is the date when the court will review the settlement and determine whether it will be finalized.
These dates are crucial for anyone who wants to participate in the settlement or exercise their legal rights to opt out or object.
How to File a $100M Walgreens Class Action Settlement 2025 Claim?
To claim your share of the settlement, follow these simple steps:
Online Submission
- Visit the Official Website: Go to the official settlement website: SavingsClubSettlement.com.
- Complete the Claim Form: Click on “File a Claim” and fill out the required information. This includes providing details about your prescription purchases at Walgreens, as well as any necessary proof of payment.
- Submit the Claim Form: Once the form is complete, submit it online before the deadline.
Mail Submission
- Download the Claim Form: Go to the settlement website and download the physical claim form.
- Fill Out the Form: Complete the form with accurate details about your prescription purchases and personal information.
- Mail the Form: Send the completed form along with any required proof of payment to the Settlement Administrator’s address, ensuring it is postmarked by the deadline.
You can also contact the Settlement Administrator for further instructions or assistance.
Required Documentation
When filing your claim, you will need to provide documentation that proves you made qualifying purchases. This may include:
- Receipts from Walgreens
- Canceled checks or payment records
- Invoices or billing statements
- Prescription records showing the medication purchased and the payment amount
This documentation will help validate your claim and ensure that you receive the correct amount of compensation.
Exclusion and Objection Process
If you do not wish to participate in the settlement, you can opt out. Alternatively, if you believe the settlement is unfair or inadequate, you may object to it. Here’s how:
Opting Out
- Written Request: Submit a written request to exclude yourself from the settlement. Your request must be received by March 18, 2025.
- Information to Include: The request should include your name, address, and a clear statement that you wish to opt out of the settlement.
- Mail to the Administrator: Your request should be mailed to the Settlement Administrator’s address.
Objecting to the Settlement
- Written Objection: If you wish to object to the terms of the settlement, submit a written objection by March 18, 2025.
- Details of Objection: Include your name, address, and a detailed explanation of why you are objecting to the settlement.
- Mail to Both Parties: Your objection should be sent to both the Settlement Administrator and the Class Counsel at the addresses provided on the settlement website.
By following these steps, you can express your concerns or choose not to participate in the settlement.
Wells Fargo Bank Settlement 2025: Check Amount & Settlement Date
Trump & Musk Under Fire! Major Lawsuits Piling Up – Supreme Court Battle Ahead!
Benchcraft Company Class Action Lawsuit in 2025 – Check Eligibility Criteria and Payment Details!
Final Approval Hearing
A fairness hearing will take place on September 10, 2025. During this hearing, the court will review the settlement and determine whether it is fair and reasonable for all parties involved. Anyone who wishes to attend the hearing may do so, though participation is not required.
Why This Settlement Matters?
The Walgreens class action settlement highlights the importance of transparency in prescription drug pricing and the role that pharmacies and insurers play in determining the cost of medications. This case also brings attention to the complexities of pricing structures and how they can affect both consumers and insurers.
For individuals who have been affected, this settlement provides an opportunity for compensation. It is a reminder that paying attention to pricing practices at pharmacies is crucial, especially when dealing with insurance coverage and out-of-pocket costs for medications.
